ArticleProceedings of the National Academy of Sciences of the United States of America2020
Imaging breast cancer using hyperpolarized carbon-13 MRI.
Open access · bronzeAbstract readEvaluation Study
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.
0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
17.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
131 citing papers in PubMed, 200 citations in OpenAlex.
- Multi-Vendor and Multi-Site Characterization ofMagnetic resonance in medicine · 2026Article
- Hyperpolarized MRI in Oncology-A Review of Clinical Studies and Evaluation of Preclinical Liver Studies.NMR in biomedicine · 2026Review
- Quantitative Imaging of Pyruvate Metabolism in a Patient With Anaplastic Thyroid Cancer.Magnetic resonance in medicine · 2026Article
- High-resolution microtesla in-situJournal of magnetic resonance (San Diego, Calif. : 1997) · 2026Article
- First worldwide multicenter validation of the POLARIS preclinical polarizer across biological models and imaging paradigms.Research square · 2026Article
- Optimized Detection of Left Ventricular Hyperpolarized [1-Magnetic resonance in medicine · 2026Article
- Mechanistic insights into chemical exchange during the signal amplification by reversible exchange sensitization of pyruvate.Nature communications · 2026Article
- Over four minutes of pyruvate TNature communications · 2026Article
- Dynamic breast MRI with Flexible Temporal Resolution Aided by Deep Learning.Nature communications · 2026Article
- Across-cities transportableNature communications · 2026Article
- Increasing Infusion Times of Hyperpolarized [1-Magnetic resonance in medicine · 2026Article
- Ultra-low fieldCommunications chemistry · 2026Article
- Technologies and Strategies for Metabolic and Molecular Imaging With Hyperpolarized MRI.Journal of magnetic resonance imaging : JMRI · 2026Review
- Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarisedCommunications medicine · 2026Article
- A study on the prognostic assessment of triple-negative breast cancer using habitat analysis of preoperative DCE-MRI subtraction maps.Frontiers in oncology · 2026Article
- Lactate, a Spearhead of Cancer Aggressiveness: Metabolic Reprogramming, Immune Suppression, and Metastatic Progression.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026Review
- Multiparametric MRI and artificial intelligence for non-invasive HER2 assessment in breast cancer: a comprehensive review.Frontiers in medicine · 2026Review
- The Role of Tumor pH in Breast Cancer Imaging: Biology, Diagnostic Applications, and Emerging Techniques.Diagnostics (Basel, Switzerland) · 2025Review
- Upscaling the Hyperpolarization Sample Volume of an Automated Hydrogenative Parahydrogen-Induced Polarizer.ACS measurement science au · 2025Article
- Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review).International journal of oncology · 2025Review
71 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
44 authors at 4 institutions in 3 countries.
Ferdia A GallagherDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.ORCID 0000-0003-4784-5230
Ramona WoitekDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom; rw585@cam.ac.uk.ORCID 0000-0002-9146-9159
Mary A McLeanDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Andrew B GillDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Raquel Manzano GarciaCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0002-5124-8992
Elena ProvenzanoCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Frank RiemerDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Joshua KaggieDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Anita ChhabraPharmacy Department, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom.ORCID 0000-0002-9899-8010
Stephan UrsprungDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
James T GristDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.ORCID 0000-0001-7223-4031
Charlie J DanielsDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Fulvio ZaccagnaDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Marie-Christine LaurentDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Matthew LockeDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Sarah HilborneDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Amy FraryDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Turid TorheimCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0001-6191-2036
Chris BoursnellCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Amy SchillerDepartment of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Ilse PattersonDepartment of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Rhys SloughDepartment of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Bruno CarmoDepartment of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Justine KaneCambridge Breast Cancer Research Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Heather BiggsCambridge Breast Cancer Research Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Emma HarrisonCambridge Breast Cancer Research Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
Surrin S DeenDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.ORCID 0000-0002-6206-7337
Andrew PattersonDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Titus LanzRAPID Biomedical GmbH, 97222 Rimpar, Germany.
Zoya KingsburyMedical Genomics Research, Illumina, Great Abington, Cambridge CB21 6DF, United Kingdom.
Mark RossMedical Genomics Research, Illumina, Great Abington, Cambridge CB21 6DF, United Kingdom.
Bristi BasuCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Richard BairdCambridge Breast Cancer Research Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
David J LomasDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Evis SalaDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
James WasonMedical Research Council Biostatistics Unit, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Oscar M RuedaCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Suet-Feung ChinCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Ian B WilkinsonDepartment of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Martin J GravesDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Jean E AbrahamCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Fiona J GilbertDepartment of Radiology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Carlos CaldasCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Kevin M BrindleCancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
University of Cambridge · GBNational Health Service · GBIllumina (United Kingdom) · GBRAPID Biomedical (Germany) · DE
Funding
Austrian Science Fund FWF J 4025Cancer Research UK 16465Cancer Research UK 16628Cancer Research UK 16942Cancer Research UK 17242Cancer Research UK 21491Cancer Research UK 27150Cancer Research UK 28289Cancer Research UK 28667Cancer Research UK C19212/A16628Cancer Research UK C19212/A911376Cancer Research UK C197/A16465Cancer Research UK C8742/A18097Cancer Research UK C9685/A25177Department of HealthMedical Research Council MC_UU_00002/16Medical Research Council MC_UU_00002/6Wellcome Trust
Abstract
Our purpose is to investigate the feasibility of imaging tumor metabolism in breast cancer patients using
Indexed as
Breast NeoplasmsCarbon IsotopesFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitL-Lactate DehydrogenaseMagnetic Resonance ImagingMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersMuscle ProteinsPyruvic AcidSymportersCarbon-13Carbon IsotopesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitL-Lactate DehydrogenaseMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersMuscle ProteinsPyruvic AcidSLC16A4 protein, humanSymportersbreast cancercancer metabolismmagnetic resonance imagingmetabolic imaging
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.